ArticleJournal of robotic surgery2025
Does age affect functional and perioperative outcomes after robotic-assisted prostatectomy in localized prostate cancer?
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting extraperitoneal ssRARP difficulty: an MRI-based nomogram.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic-assisted laparoscopic prostatectomy (RALP) is widely accepted for treating localized prostate cancer, particularly in low- and intermediate-risk groups. However, the impact of advancing age on postoperative continence recovery and complication rates remains uncertain, often influencing treatment decisions in elderly patients. To evaluate the influence of age on continence outcomes and perioperative complications following RALP in patients with low- and intermediate-risk prostate cancer. This retrospective study included 439 patients undergoing RALP, stratified into three age groups: ≤ 60 years (n = 133), 61-70 years (n = 221), and > 70 years (n = 85). Baseline demographic, perioperative, pathological, continence recovery, and biochemical recurrence outcomes were compared across groups. Continence was assessed at 3, 6, 12, and 24 months postoperatively. Complication rates were classified using the Clavien-Dindo system. Higher comorbidity scores (≥ 3) were more frequent in patients over 70 years (25.9% vs. 9% in ≤ 60 years, p = 0.022). Mean preoperative PSA was significantly higher in the oldest group (7.67 vs. 6.54 ng/mL, p = 0.039). Operative time and estimated blood loss were similar across groups (p = 0.138 and p = 0.677). Length of stay showed a trend toward longer hospitalization in older patients (≥ 3 days: 21.2% in > 70 vs. 7.5% in ≤ 60 years, p = 0.058). Pathological staging and Gleason grades were comparable (p > 0.3). Continence recovery at 3 months was similar (70.6-72.2%, p = 0.27), with slightly lower rates at 1 year in patients > 70 years (77.6% vs. 88.0% in ≤ 60). Biochemical recurrence rates and adjuvant therapy usage did not differ significantly (p > 0.6). Only 3 major complications exceeding Clavien-Dindo grade 2 were reported (p > 0.8). RALP is safe and effective across age groups, including elderly patients, with comparable oncologic and functional outcomes. Age alone should not preclude consideration of RALP in appropriately selected patients. These findings support individualized counseling and treatment planning to optimize outcomes in older adults.
Indexed as
Identifiers
40956398What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.